VIOLA BLACKWELL: Open Payments
NPI 1538858246 · WHITEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 34 payments from 13 companies in 2025. Trend: 2023 $112 · 2024 $752 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $212 |
| Novo Nordisk Inc | 10 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Ardelyx, Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Corcept Therapeutics | 2 | $34 |
| Amgen Inc. | 1 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: BREZTRI, Ozempic, Kerendia, IBSRELA, FARXIGA, CAPLYTA, Korlym, REPATHA.
Industry payments across NC — which companies pay providers there.
